Milmed Unico AB
Early-stage developer of patented medicinal probiotics for chronic diseases.
Översikt
- 1
- Anställda
- 78t SEK
- Omsättning
- 2018
- Grundat
Nyckelbeslutsfattare
Johan Olsson
Board Member
Anna Linton
Board Member
Thomas Lenz
CEO
Tatiana Blomqvist
Production and Lab Manager
+8 fler kontakter i Funnelfeedr
Beskrivning
Milmed Unico AB is an early-stage biotechnology company focused on developing groundbreaking medicinal probiotics. Their core technology is based on a patented, non-toxic yeast culture that has shown positive impacts on living cells. The company holds patent protection for treatments targeting three...